MALARIA VACCINES MARKET ANALYSIS

Malaria Vaccines Market, by Agent (Plasmodium Falciparum, Plasmodium Vivax and Anopheles Species), by Vaccine Type (Pre-Erythrocytic, Erythrocytic and Multi-antigen), by Distribution Channel (Public and Private) and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jun 2022
Code : CMI37
Pages :166
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Increasing government initiatives for prevention of malaria are expected to drive market growth during the forecast period.

Increasing government initiatives for prevention of malaria are expected to drive the global malaria vaccines market growth over the forecast period. For instance, in October 2021, the World Health Organization (WHO) recommended widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children in sub-Saharan Africa and in other regions with moderate to high P. falciparum malaria transmission. The recommendation was based on results from an ongoing pilot programme in Ghana, Kenya and Malawi that has reached more than 900 000 children since 2019.

Restraints & Challenges: